Overcoming Drug Interference in Transfusion Testing: A Spotlight on Daratumumab

Daratumumab, a monoclonal antibody therapeutic, is highly efficacious and widely used in all stages of multiple myeloma and amyloidosis and has promising activity in other hematologic disorders. Daratumumab interacts with red blood cells, interfering with pre-transfusion testing. This interference c...

Descripción completa

Detalles Bibliográficos
Autores principales: Nedumcheril, Marilyn T, DeSimone, Robert A, Racine-Brzostek, Sabrina E, Chaekal, Ok Kyong, Vasovic, Ljiljana V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164699/
https://www.ncbi.nlm.nih.gov/pubmed/34079412
http://dx.doi.org/10.2147/JBM.S213510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164699/
https://www.ncbi.nlm.nih.gov/pubmed/34079412
http://dx.doi.org/10.2147/JBM.S213510

Ejemplares similares